US healthcare giant Johnson & Johnson has started work on a vaccine against the Wuhan novel coronavirus.
To continue reading The Pharma Letter please login , subscribe or Claim a 7 day free trial subscription and access exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space.
Antibiotics and Infectious diseases
Asia Pacific
China Focus On Janssen Johnson & Johnson Pharmaceutical (Public health ) (Research ). (USA Vaccines
No-limits access to our site with up-to-the minute news
- Personalized news and email alerts
- Online discussion forums and Q&A section
- RSS news feeds that you can add to your favorite reader, or website
- daily news email alert, with the breaking news stories and news roundup Click here to subscribe
“Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products . It’s part of the key information for keeping me informed ” Nigel Brooksby, Chairman, Sanofi aventis UK Ltd
(Read More)
GIPHY App Key not set. Please check settings